Bernstein raised its price target on Pfizer (NYSE: PFE) to $44.00 (from $43.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Pfizer (PFE) PT Raised to $39 at Credit SuisseJanuary 31, 2018 10:22 AM Pfizer (PFE) PT Raised to $42 at BofA/Merrill LynchJanuary 31, 2018 9:56 AM Pfizer (PFE) PT Raised to $43 at Morgan StanleyJanuary 31, 2018 9:47 AM Pfizer (PFE) PT Raised to $42 at UBSJanuary 31, 2018 9:37 AM Pfizer (PFE) PT Raised to $38 at Leerink PartnersJanuary 31, 2018 7:47 AM Pfizer (PFE) PT Raised to $42 at Deutsche Bank Following 4Q January 31, 2018 7:39 AM Pfizer (PFE) PT Raised to $43 at Morgan StanleyJanuary 31, 2018 7:29 AM Pfizer (PFE) PT Raised to $43 at BMO CapitalJanuary 31, 2018 5:01 AM Pfizer (PFE) PT Raised to $41 at BarclaysJanuary 31, 2018 4:05 AM AbbVie (ABBV), Eli Lilly (LLY) More Vulnerable Than Other Drug Cos. on Amazon Entry - BMOJanuary 30, 2018 3:01 PM Pfizer (PFE) Not Hungry for a Large Deal - BMOJanuary 30, 2018 12:54 PM Teva Pharma (TEVA) Set to Open Lower by 7%January 30, 2018 8:25 AM Pfizer's new tax rate higher than investors hoped, shares fallJanuary 30, 2018 7:03 AM Pfizer (PFE) Tops Q4 EPS by 6c, FY18 EPS Guidance Beats, Sees $15B Repatriation Tax LiabilityJanuary 30, 2018 6:46 AM Pfizer (PFE) PT Raised to $40 at SunTrust Robinson Humphrey After Raising EPS Estimate to Reflect Lower Tax RateJanuary 29, 2018 4:42 AM